Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 531 (1) , 51-55
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 63 references indexed in Scilit:
- C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA fociActa Neuropathologica, 2013
- C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexesScientific Reports, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- A Sequence-Independent Analysis of the Loop Length Dependence of Intramolecular RNA G-Quadruplex Stability and TopologyBiochemistry, 2011
- ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndromeNature Structural & Molecular Biology, 2011
- Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?Nature Reviews Drug Discovery, 2011
- RNA and DiseaseCell, 2009
- Mutations in the chromatin-associated protein ATRXHuman Mutation, 2008
- Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosisNature, 1988